IL64253A0 - Dimeric 1,4-dihydropyridine compounds linked in the c-3 position,their production and pharmaceutical compositions containing them - Google Patents

Dimeric 1,4-dihydropyridine compounds linked in the c-3 position,their production and pharmaceutical compositions containing them

Info

Publication number
IL64253A0
IL64253A0 IL64253A IL6425381A IL64253A0 IL 64253 A0 IL64253 A0 IL 64253A0 IL 64253 A IL64253 A IL 64253A IL 6425381 A IL6425381 A IL 6425381A IL 64253 A0 IL64253 A0 IL 64253A0
Authority
IL
Israel
Prior art keywords
carbon atoms
different
phenyl
alkyl
hydroxyl
Prior art date
Application number
IL64253A
Other versions
IL64253A (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL64253A0 publication Critical patent/IL64253A0/en
Publication of IL64253A publication Critical patent/IL64253A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1. 1,4-Dihydropyridines which are linked in the C-3 position, of the general formula I see diagramm : EP0052300,P19,F4 in which R and R' are identical or different and each represent a phenyl radical or a thienyl, furyl, or pyridyl radical, the phenyl radical is optionally substituted by one or two identical or different substituents from the group comprising nitro, cyano, azido, halogen, trifluoromethyl, hydroxyl, amino, alkyl, alkoxy, alkylamino or alkylmercapto, with in each case 1 or 2 carbon atoms in the alkyl groups, R**1 and R**1' are identical or different and each represent a straight-chain or branched hydrocarbon radical having up to 6 carbon atoms which is optionally interrupted in the chain by an oxygen atom and which is optionally substituted by fluorine, chlorine, hydroxyl, phenyl or phenoxy, R**2 , R**2' , R**4 and R**4' are identical or different and each represent hydrogen or a straight-chain or branched alkyl radical which has up to 4 carbon atoms and which is optionally substituted by fluorine, chlorine, hydroxyl, phenyl or amino, R**3 and R**3' are identical or different and each represent hydrogen, alkyl having 1 to 4 carbon atoms, phenyl, benzyl or phenethyl, optionally substituted by hydroxyl, fluorine or chlorine, Y and Y' are in each case identical or different and each denote - COO -, - CONH -, - CO - or - SO2 - and X denotes a bridge member which consists of one to ten CH2 groups as the chain member, and none of these CH2 groups are allowed as a ring member, it being possible for this bridge member additionally to contain, in any sequence, 1 to 3 identical or different chain members from the group comprising O, S, CO, CS, NR**5 , C(R**6 )2 , CH = N, phenylene, naphthylene, pyrrylene, cycloalkylene with 5 to 7 carbon atoms, piperazinylene, piperidinylene, pyrrolidinylene or morpholinylene, wherein R**5 represents hydrogen, benzyl or alkyl having 1 to 4 carbon atoms and R**6 represents hydrogen, benzyl, phenyl, fluorine, chlorine, alkyl having 1 to 4 carbon atoms, hydroxyl, trifluoromethyl, cyano, carboxyl or amino and their pharmacologically acceptable acid addition salts.
IL64253A 1980-11-13 1981-11-10 Dimeric 1,4-dihydropyridine compounds linked in the c-3 position,their production and pharmaceutical compositions containing them IL64253A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042769 DE3042769A1 (en) 1980-11-13 1980-11-13 C-3 LINKED 1,4-DIHYDROPYRIDINE, THEIR USE IN MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
IL64253A0 true IL64253A0 (en) 1982-02-28
IL64253A IL64253A (en) 1985-03-31

Family

ID=6116648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL64253A IL64253A (en) 1980-11-13 1981-11-10 Dimeric 1,4-dihydropyridine compounds linked in the c-3 position,their production and pharmaceutical compositions containing them

Country Status (16)

Country Link
EP (1) EP0052300B1 (en)
JP (1) JPS57109766A (en)
AT (1) ATE11773T1 (en)
AU (1) AU546605B2 (en)
CA (1) CA1179342A (en)
DD (1) DD201900A5 (en)
DE (2) DE3042769A1 (en)
DK (1) DK501881A (en)
ES (3) ES507080A0 (en)
FI (1) FI813567L (en)
GR (1) GR76338B (en)
HU (1) HU186438B (en)
IL (1) IL64253A (en)
NO (1) NO813649L (en)
PT (1) PT73920B (en)
ZA (1) ZA817840B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (en) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
EP0094159B1 (en) * 1982-05-10 1990-03-14 Takeda Chemical Industries, Ltd. Dihydropyridine derivatives, their production and use
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (en) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Composés amidés
JPS60120861A (en) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd Dihydropyridine derivative
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
IT1203900B (en) * 1987-04-15 1989-02-23 Lagor Spa POLES 1,4-DIHYDRO-2,6-DIMETHYLPYRIDIN 3,5-DICARBOXYESTERS USEFUL AS THERMAL STABILIZERS FOR SYNTHETIC POLYMERS
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
US6897305B2 (en) 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
JP2002517440A (en) * 1998-06-08 2002-06-18 アドバンスド メディスン インコーポレーテッド New calcium channel drugs and uses
US7101909B2 (en) 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795789A1 (en) * 1966-11-16 1975-07-31 Astra Ab PYRIDINE DERIVATIVES, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THEM
DE2117571C3 (en) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals
DE2847236A1 (en) * 1978-10-31 1980-05-14 Bayer Ag NEW DIHYDROPYRIDINE WITH SUBSTITUTED ESTER GROUPS, MORE PROCEDURES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS

Also Published As

Publication number Publication date
EP0052300A1 (en) 1982-05-26
GR76338B (en) 1984-08-04
ES8206477A1 (en) 1982-08-16
ES8303337A1 (en) 1983-02-01
ES510253A0 (en) 1983-02-01
ES8303336A1 (en) 1983-02-01
DD201900A5 (en) 1983-08-17
FI813567L (en) 1982-05-14
CA1179342A (en) 1984-12-11
DE3168955D1 (en) 1985-03-28
JPS57109766A (en) 1982-07-08
ZA817840B (en) 1982-10-27
ATE11773T1 (en) 1985-02-15
AU546605B2 (en) 1985-09-12
PT73920A (en) 1981-12-01
ES510254A0 (en) 1983-02-01
ES507080A0 (en) 1982-08-16
HU186438B (en) 1985-07-29
DE3042769A1 (en) 1982-06-09
AU7711081A (en) 1982-05-20
DK501881A (en) 1982-05-14
IL64253A (en) 1985-03-31
EP0052300B1 (en) 1985-02-13
PT73920B (en) 1983-03-29
NO813649L (en) 1982-05-14

Similar Documents

Publication Publication Date Title
IL64253A (en) Dimeric 1,4-dihydropyridine compounds linked in the c-3 position,their production and pharmaceutical compositions containing them
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
DE3583872D1 (en) DIHYDROPYRIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHOD FOR THE PRODUCTION OF THESE COMPOSITIONS.
ES463803A1 (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
DE3561819D1 (en) Derivatives of methylenediphosphonic acid, process for their preparation and antirheumatic pharmaceutical compositions containing them
KR840000493A (en) Method for preparing herbicide comprising amide and ester group derived from pyridine
ATE45878T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING FLAVES OR THIOFLAVEN DERIVATIVES, THEIR USE, FLAVENES AND THIOFLAVENES AND PROCESSES FOR THEIR MANUFACTURE.
ATE42555T1 (en) NEW SULFONYL(THIO) UREAS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES AND/OR GROWTH REGULATORS.
ATE38675T1 (en) PHOSPHATE ESTER DERIVATIVES AND THEIR USE AS AN ANTI-CANCER AGENT.
ES444879A1 (en) Dicarboxylic acid derivatives of triiodoisophthalic acid monamino acid amides process for their manufacture and their use as x-ray contrast agents
ES457575A2 (en) Sulphur-containing diaryl compounds and oxygen-containing diaryl compounds
KR890000468A (en) Sulfonylurea-herbicides, methods for their preparation, preparations containing them and their uses
ATE9222T1 (en) 4,4-DISUBSTITUTED 1,4-DIHYDROPYRIDINES, PROCESSES FOR THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICALS.
JPS5754185A (en)